133 related articles for article (PubMed ID: 36221355)
1. Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review.
Wang CQ; Liu FY; Wang W
Medicine (Baltimore); 2022 Oct; 101(40):e30749. PubMed ID: 36221355
[TBL] [Abstract][Full Text] [Related]
2. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis.
Biaoxue R; Xiguang C; Hua L; Wenlong G; Shuanying Y
BMC Cancer; 2016 Nov; 16(1):888. PubMed ID: 27842514
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of Endostar combined with platinum pleural infusion for malignant pleural effusion in tumor patients is significantly better than that of monotherapy, but the economy is lower: a systematic review, network meta-analysis and cost-effectiveness analysis.
Xia Y; Fang P; Zhang X; Su G; Shen A
Ann Transl Med; 2022 May; 10(10):604. PubMed ID: 35722417
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
Hu Y; Zhou Z; Luo M
Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
[TBL] [Abstract][Full Text] [Related]
5. [A Meta-Analysis of Efficacy and Adverse Effects of Lobaplatin and Cisplatin in the Treatment of Malignant Pleural Effusion].
Min S; Zheng Q; Zhang B; Yan D; Wang R; Qu Z; Li L; Liu J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):90-98. PubMed ID: 30827325
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal Perfusion Therapy of Endostar Combined with Platinum Chemotherapy for Malignant Serous Effusions: A Meta-analysis.
Liang R; Xie HY; Lin Y; Li Q; Yuan CL; Liu ZH; Li YQ
Asian Pac J Cancer Prev; 2015; 16(18):8637-44. PubMed ID: 26745130
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
Rong B; Yang S; Li W; Zhang W; Ming Z
World J Surg Oncol; 2012 Aug; 10():170. PubMed ID: 22917490
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of endostar combined with cisplatin/ pemetrexed chemotherapy for elderly patients with advanced malignant pleural effusion of lung adenocarcinoma.
Jie Wang X; Miao K; Luo Y; Li R; Shou T; Wang P; Li X
J BUON; 2018; 23(1):92-97. PubMed ID: 29552766
[TBL] [Abstract][Full Text] [Related]
9. Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer.
Fu T; Lin Y; Zeng Q; Yao W; Han L
BMC Pulm Med; 2020 Jun; 20(1):175. PubMed ID: 32552897
[TBL] [Abstract][Full Text] [Related]
10. Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.
Zhao WY; Chen DY; Chen JH; Ji ZN
Cell Biochem Biophys; 2014 Sep; 70(1):623-8. PubMed ID: 24920191
[TBL] [Abstract][Full Text] [Related]
11. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
Chen L; Zhu X; Li D; Cai X
J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
[TBL] [Abstract][Full Text] [Related]
13. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
Asian Pac J Cancer Prev; 2011; 12(11):2901-7. PubMed ID: 22393961
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.
Biaoxue R; Hui P; Wenlong G; Shuanying Y
Sci Rep; 2016 Dec; 6():39355. PubMed ID: 27976709
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Xu L; Wang B; Gao M; Zhang Y; Qi Q; Li T; Li C; Wang A; Li Y
Thorac Cancer; 2018 Aug; 9(8):950-955. PubMed ID: 29917319
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhu G; Wang X; Li J; Zhang Y; Gao R; Zhang X; Xu B; Hu J; Dai M; Chen J
Front Pharmacol; 2021; 12():694129. PubMed ID: 34803667
[No Abstract] [Full Text] [Related]
18. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
An J; Lv W
Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies for malignant pleural effusion: Anti‑angiogenic therapy and immunotherapy (Review).
He D; Ding R; Wen Q; Chen L
Int J Oncol; 2021 Mar; 58(3):359-370. PubMed ID: 33650668
[TBL] [Abstract][Full Text] [Related]
20. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
Asian Pac J Cancer Prev; 2011; 12(10):2705-11. PubMed ID: 22320978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]